Piramal Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '25
Dec '24
Sep '24
Jun '24
Mar '24
Total Qtr Revenue cr
2,796.10
2,216.35
2,302.86
1,970.68
2,578.74
Other Income Qtr Cr42.0312.1361.1119.5426.38
Operating Revenues Qtr2,754.072,204.222,241.751,951.142,552.36

*All values are in Cr.

Operating Expenses Qtr
2,193.08
1,866.48
1,900.14
1,746.65
2,022.43
Operating Profit Qtr
560.99
337.74
341.61
204.49
529.93
EBITDA Qtr Cr
603.02
349.87
402.72
224.03
525.79
Depreciation Qtr
242.76
196.81
192.22
184.55
196.13
Net Profit Qtr
153.50
3.68
22.59
-88.64
101.27
Basic EPS Qtr
1.16
0.03
0.17
-0.67
0.77
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -